Here, using MTT cell viability assay and AnnexinV/PI analysis, we demonstrate that Derlin-1 confers cisplatin resistance and reduced apoptosis in bladder cancer cell lines. This evidence concerns the gene DERL1 and urinary bladder carcinoma.